The Theme
Valproate (VPA) is a drug used in the treatment of epilepsy, bipolar disorder and spinal muscular atrophy. Epilepsy affects around 50 million people worldwide. A biosensor for the measurement of VPA could help to the quality of life by personalizing VPA treatment.
The Organization
prof. dr. ir. Menno Prins
Founder and Guide
Yannick Leurs
Chair
Iris Schilthuis
Vice-Chair
Judith Hoekstra
Treasurer
Renate Janssen
Secretary
Jolien Marcelis
Events
Ingrid Kolen
Events
Stijn van Wijngaarden
Events
Miriam Laamoumi
External Relations
Fleur Kloosterman
External Relations
Maartje Wilms
External Relations
Cecile Hamming
Public Relations
Tatum Simons
Public Relations
Jorrit Baartman
Technology
Henry Kwan
Technology
Ivana Stijepovic
Technology